| Literature DB >> 34886860 |
Zhengcheng Liu1, Louqian Zhang1, Weifeng Tang1, Rusong Yang2.
Abstract
BACKGROUND: To describe a technique of non-intubated uniportal subxiphoid thoracoscopic extended thymectomy.Entities:
Keywords: Myasthenia gravis; Non-intubated; Subxiphoid; Thymectomy; Uniport
Mesh:
Year: 2021 PMID: 34886860 PMCID: PMC8655993 DOI: 10.1186/s12957-021-02430-z
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Fig. 1A single transverse incision was made below the lower edge of the xiphoid
Fig. 2Radical removal of the lesion and the entire thymus gland with fat tissue was accomplished
Peri-operative data of patients
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sex | Male | Male | Female | Male | Female | Female | Male | Female | Female | Male |
| Age | 41 | 55 | 39 | 51 | 53 | 36 | 58 | 43 | 36 | 45 |
| FEV1(L) | 2.94 | 3.11 | 2.52 | 2.77 | 2.98 | 2.85 | 3.38 | 2.46 | 3.02 | 3.46 |
| Smoking status | Cessation | No | No | Cessation | No | No | Cessation | No | No | No |
| Body mass index (kg/m2) | 23.7 | 22.4 | 25.1 | 24.2 | 23.9 | 22.6 | 23.5 | 22.1 | 24.7 | 23.5 |
| ASA score | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Thoracic adhesion | No | No | No | Mild | No | No | No | No | No | No |
| Operation time (min) | 95 | 105 | 115 | 125 | 90 | 95 | 100 | 85 | 110 | 105 |
| Chest tube drainage (days) | 3 | 3 | 5 | 4 | 3 | 4 | 3 | 4 | 3 | 3 |
| Postoperative hospital stay (days) | 4 | 5 | 7 | 5 | 4 | 5 | 4 | 5 | 4 | 4 |
| Pain in postoperative day 1 (VAS) | 2 | 3 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 2 |
| Pain in postoperative day 3 (VAS) | 2 | 3 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| Pain in postoperative day 7 (VAS) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Myasthenia gravis classification (before operation) | IIB | IIA | I | I | IIA | IIA | I | I | IIA | I |
| Preoperative QMG score | 6 | 6 | 2 | 3 | 5 | 5 | 2 | 3 | 5 | 3 |
| Preoperative duration of symptoms (months) | 9 | 3 | 2 | 1 | 2 | 6 | 2 | 3 | 2 | 12 |
| Pathology type | AB | B1 | A | B2 | AB | B2 | B1+B2 | B1 | B1 | AB |
| Masaoka stage | I | IIA | I | IIA | I | IIA | IIA | I | IIA | I |
| Maximal diameter (mm) | 29 | 22 | 19 | 45 | 33 | 23 | 35 | 28 | 30 | 26 |
| Lymph node invasion | No | No | No | No | No | No | No | No | No | No |
| Follow-up (months) | 21 | 19 | 17 | 16 | 13 | 12 | 10 | 9 | 9 | 8 |
| Postoperative QMG score (6 months) | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 3 | 1 |
| Myasthenic crisis | No | No | No | No | No | No | No | No | No | No |
| Myasthenia gravis status (after operation) | Improved | Improved | Improved | Improved | Improved | Improved | Improved | Improved | Improved | Improved |
| Thymoma recurrence | No | No | No | No | No | No | No | No | No | No |